Healthcare -
Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
KPTI - LONG-TERM DEBT
Long-term Debt KPTI - Karyopharm Therapeutics Inc.
99.5 M
LAST VALUE
-24.86%
2 YEAR CAGR
-4.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR